MAQUET PLEGIOX Cardioplegia Heat Exchanger The PLEGIOX Cardioplegia Heat Exchanger is used as part of a cardioplegia system to set and maintain temperature for given flow rates and within the given temperature range of blood cardioplegic and crystalloid cardioplegic solutions during extracorporeal circulation. The product is designed for single use only, for an application period of no longer than 6 hours.
FDA Recall Z-1165-2014 · Posted 2014-03-10
Advertisement
Recalling FirmMaquet Cardiovascular Us Sales, Llc
Recall StatusTerminated
Product CodeDTR
Date Initiated2014-01-31
Date Terminated2015-04-24
Product Quantity1,424 units
Reason for Recall
The MAQUET post-marketing vigilance program has identified a discrepancy that the
desired cardioplegia temperature may not be obtained when the PLEGIOX Cardioplegia
Heat Exchanger (PLEGIOX) is used in conjunction with a heater/cooler unit.
Firm Action
Maquet Inc.sent an" Field Safety Notice" dated January 31, 2014, to all affected customers via Fed Ex. The letter identified the product the problem and the action needed to be taken by the customer.
Any questions or additional information, can be obtained from the MAQUET representative, or MAQUET Customer Service at 1-888-627-8383 (press option 2, followed by option 3), Monday through Friday, between the hours of 8:00 a.m. and 6:00 p.m. EST.
Please complete and return the enclosed confirmation form, acknowledging your receipt and understanding of this communication, by emailing a scanned copy to [email protected] or via fax at (973) 807-9290.
Root Cause
Device Design
Distribution Pattern
Worldwide Distribution - USA (nationwide) and the countries of Brazil, Germany and Turkey
Related FDA 510(k) Records
Devices referenced by this recall via K-numbers.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement